A Molecule Targeting VHL-Deficient Renal Cell Carcinoma that Induces Autophagy

Aita, 1999, Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21, Genomics, 59, 59, 10.1006/geno.1999.5851 An, 2005, VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism, Oncogene, 24, 1563, 10.1038/sj.onc.1208348 Bursch, 1996, Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy, Carcinogenesis, 17, 1595, 10.1093/carcin/17.8.1595 Castro, 1999, Uridine diphosphate-glucose transport into the endoplasmic reticulum of Saccharomyces cerevisiae: in vivo and in vitro evidence, Mol. Biol. Cell, 10, 1019, 10.1091/mbc.10.4.1019 Chan, 2002, Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha, J. Biol. Chem., 277, 40112, 10.1074/jbc.M206922200 Corcelle, 2006, Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity, Cancer Res., 66, 6861, 10.1158/0008-5472.CAN-05-3557 Crighton, 2006, DRAM, a p53-induced modulator of autophagy, is critical for apoptosis, Cell, 126, 121, 10.1016/j.cell.2006.05.034 Crighton, 2007, p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death, Cell Death Differ., 14, 1071, 10.1038/sj.cdd.4402108 Ellington, 2005, Induction of macroautophagy in human colon cancer cells by soybean B-group triterpenoid saponins, Carcinogenesis, 26, 159, 10.1093/carcin/bgh297 Erler, 2006, Lysyl oxidase is essential for hypoxia-induced metastasis, Nature, 440, 1222, 10.1038/nature04695 Ertmer, 2007, The anticancer drug imatinib induces cellular autophagy, Leukemia, 21, 936, 10.1038/sj.leu.2404606 Eskelinen, 2002, Role of LAMP-2 in lysosome biogenesis and autophagy, Mol. Biol. Cell, 13, 3355, 10.1091/mbc.E02-02-0114 Fish, 2007, Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase, J. Biol. Chem., 282, 15652, 10.1074/jbc.M608318200 Furuya, 2005, The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function, Autophagy, 1, 46, 10.4161/auto.1.1.1542 Giaccia, 2003, HIF-1 as a target for drug development, Nat. Rev. Drug Discov., 2, 803, 10.1038/nrd1199 Gnarra, 1996, Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene, Proc. Natl. Acad. Sci. USA, 93, 10589, 10.1073/pnas.93.20.10589 Gozuacik, 2007, Autophagy and cell death, Curr. Top. Dev. Biol., 78, 217, 10.1016/S0070-2153(06)78006-1 Gutierrez, 2004, Rab7 is required for the normal progression of the autophagic pathway in mammalian cells, J. Cell Sci., 117, 2687, 10.1242/jcs.01114 Hartman, 2001, Principles for the buffering of genetic variation, Science, 291, 1001, 10.1126/science.291.5506.1001 Heesen, 1994, Isolation of the ALG5 locus encoding the UDP-glucose:dolichyl-phosphate glucosyltransferase from Saccharomyces cerevisiae, Eur. J. Biochem., 224, 71, 10.1111/j.1432-1033.1994.tb19996.x Hergovich, 2003, Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL, Nat. Cell Biol., 5, 64, 10.1038/ncb899 Iliopoulos, 1995, Tumour suppression by the human von Hippel-Lindau gene product, Nat. Med., 1, 822, 10.1038/nm0895-822 Iliopoulos, 1996, Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein, Proc. Natl. Acad. Sci. USA, 93, 10595, 10.1073/pnas.93.20.10595 Isaacs, 2002, Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway, J. Biol. Chem., 277, 29936, 10.1074/jbc.M204733200 Ito, 2005, Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells, Int. J. Oncol., 26, 1401 Ivan, 2001, HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science, 292, 464, 10.1126/science.1059817 Jaakkola, 2001, Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation, Science, 292, 468, 10.1126/science.1059796 Jin, 2007, Metabolic catastrophe as a means to cancer cell death, J. Cell Sci., 120, 379, 10.1242/jcs.03349 Kabeya, 2000, LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing, EMBO J., 19, 5720, 10.1093/emboj/19.21.5720 Kaelin, 2005, The concept of synthetic lethality in the context of anticancer therapy, Nat. Rev. Cancer, 5, 689, 10.1038/nrc1691 Kanzawa, 2003, Induction of autophagic cell death in malignant glioma cells by arsenic trioxide, Cancer Res., 63, 2103 Kihara, 2001, Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network, EMBO Rep., 2, 330, 10.1093/embo-reports/kve061 Klionsky, 2000, Autophagy as a regulated pathway of cellular degradation, Science, 290, 1717, 10.1126/science.290.5497.1717 Knebelmann, 1998, Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor, Cancer Res., 58, 226 Kochl, 2006, Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes, Traffic, 7, 129, 10.1111/j.1600-0854.2005.00368.x Kondo, 2003, Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth, PLoS Biol., 1, E83, 10.1371/journal.pbio.0000083 Kondo, 2005, The role of autophagy in cancer development and response to therapy, Nat. Rev. Cancer, 5, 726, 10.1038/nrc1692 Lee, 2007, ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration, Curr. Biol., 17, 1561, 10.1016/j.cub.2007.07.029 Lolkema, 2005, Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain, J. Biol. Chem., 280, 22205, 10.1074/jbc.M503220200 Mabjeesh, 2003, 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF, Cancer Cell, 3, 363, 10.1016/S1535-6108(03)00077-1 Mathew, 2007, Autophagy suppresses tumor progression by limiting chromosomal instability, Genes Dev., 21, 1367, 10.1101/gad.1545107 Mizushima, 2001, Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells, J. Cell Biol., 152, 657, 10.1083/jcb.152.4.657 Moeller, 2005, Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity, Cancer Cell, 8, 99, 10.1016/j.ccr.2005.06.016 Na, 2003, Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein, EMBO J., 22, 4249, 10.1093/emboj/cdg410 Nazarko, 2007, Autophagy-related pathways and specific role of sterol glucoside in yeasts, Autophagy, 3, 263, 10.4161/auto.3907 Ogata, 2006, Autophagy is activated for cell survival after endoplasmic reticulum stress, Mol. Cell. Biol., 26, 9220, 10.1128/MCB.01453-06 Ohh, 1998, The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix, Mol. Cell, 1, 959, 10.1016/S1097-2765(00)80096-9 Okuda, 2001, The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C, J. Biol. Chem., 276, 43611, 10.1074/jbc.M107880200 Opipari, 2004, Resveratrol-induced autophagocytosis in ovarian cancer cells, Cancer Res., 64, 696, 10.1158/0008-5472.CAN-03-2404 Oya, 2001, Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells, Oncogene, 20, 3888, 10.1038/sj.onc.1204525 Patel, 2006, Targeting von Hippel-Lindau pathway in renal cell carcinoma, Clin. Cancer Res., 12, 7215, 10.1158/1078-0432.CCR-06-2254 Perry, 2006, Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein, Mol. Biol. Cell, 17, 2604, 10.1091/mbc.E06-01-0060 Qi, 2003, The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway, Cancer Res., 63, 7076 Rapisarda, 2002, Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway, Cancer Res., 62, 4316 Smukste, 2006, Using small molecules to overcome drug resistance induced by a viral oncogene, Cancer Cell, 9, 133, 10.1016/j.ccr.2006.01.012 Sosman, 2007, Opportunities and obstacles to combination targeted therapy in renal cell cancer, Clin. Cancer Res., 13, 764s, 10.1158/1078-0432.CCR-06-1975 Staller, 2003, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL, Nature, 425, 307, 10.1038/nature01874 Sutphin, 2004, Dead cells don't form tumors: HIF-dependent cytotoxins, Cell Cycle, 3, 160, 10.4161/cc.3.2.617 Takeuchi, 2005, Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors, Cancer Res., 65, 3336, 10.1158/0008-5472.CAN-04-3640 Tanida, 2002, Human Apg3p/Aut1p homologue is an authentic E2 enzyme for multiple substrates, GATE-16, GABARAP, and MAP-LC3, and facilitates the conjugation of hApg12p to hApg5p, J. Biol. Chem., 277, 13739, 10.1074/jbc.M200385200 Thomas, 2006, Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer, Nat. Med., 12, 122, 10.1038/nm1337 Yorikawa, 2005, Human CHMP6, a myristoylated ESCRT-III protein, interacts directly with an ESCRT-II component EAP20 and regulates endosomal cargo sorting, Biochem. J., 387, 17, 10.1042/BJ20041227 Yorimitsu, 2006, Endoplasmic reticulum stress triggers autophagy, J. Biol. Chem., 281, 30299, 10.1074/jbc.M607007200 Young, 2006, Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes, J. Cell Sci., 119, 3888, 10.1242/jcs.03172 Zimmer, 2004, Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors, Mol. Cancer Res., 2, 89, 10.1158/1541-7786.89.2.2